Comprehensive Screening of Target Molecules by Next-Generation Sequencing in Patients With Malignant Solid Tumors: Guiding Entry Into Phase I Clinical Trials

Molecular Cancer - United Kingdom
doi 10.1186/s12943-016-0553-z

Related search